bpc 157 side BPC-157 Explained: Benefits, Safety & Oral vs Injectable Options The Hidden Risks of BPC‑157:

For TB-500, "TB-500" returns the synthetic-fragment literature

As MOTS-c activates AMPK and NRF2, it also indirectly suppresses the mTOR (mechanistic target of rapamycin) pathway, the master growth and anabolism regulator that, when chronically overactivated, accelerates the accumulation of senescent cells

In C57BL/6 mice, the absence of either protein leads to deficient type I IFN production and early mortality (138, 158, 159)

And I think this is not often spoken about

It is designed to be a neutral vehicle that preserves the peptide solution without interfering with its structure or function, provided storage protocols are followed